<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the incidence of foot <z:mpath ids='MPATH_579'>ulcers</z:mpath> in a large cohort of patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, the risk of developing serious complications after diagnosis, and the attributable cost of care compared with that in patients without foot <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Retrospective cohort study of patients with <z:mp ids='MP_0002055'>diabetes</z:mp> in a large staff-model health maintenance organization from 1993 to 1995 </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:mp ids='MP_0002055'>diabetes</z:mp> were identified by algorithm using administrative, laboratory, and pharmacy records </plain></SENT>
<SENT sid="3" pm="."><plain>The data were used to calculate incidence of foot <z:mpath ids='MPATH_579'>ulcers</z:mpath>, risk of <z:hpo ids='HP_0002754'>osteomyelitis</z:hpo>, <z:mpath ids='MPATH_686'>amputation</z:mpath>, and <z:hpo ids='HP_0011420'>death</z:hpo> after diagnosis of foot <z:mpath ids='MPATH_579'>ulcer</z:mpath>, and attributable costs in foot <z:mpath ids='MPATH_579'>ulcer</z:mpath> patients compared with patients without foot <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among 8,905 patients identified with type 1 or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 514 developed a foot <z:mpath ids='MPATH_579'>ulcer</z:mpath> over 3 years of observation (cumulative incidence 5.8%) </plain></SENT>
<SENT sid="5" pm="."><plain>On or after the time of diagnosis, 77 (15%) patients developed <z:hpo ids='HP_0002754'>osteomyelitis</z:hpo> and 80 (15.6%) required <z:mpath ids='MPATH_686'>amputation</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Survival at 3 years was 72% for the foot <z:mpath ids='MPATH_579'>ulcer</z:mpath> patients versus 87% for a group of age- and sex-matched diabetic patients without foot <z:mpath ids='MPATH_579'>ulcers</z:mpath> (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>The attributable cost for a 40- to 65-year-old male with a new foot <z:mpath ids='MPATH_579'>ulcer</z:mpath> was $27,987 for the 2 years after diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The incidence of foot <z:mpath ids='MPATH_579'>ulcers</z:mpath> in this cohort of patients with <z:mp ids='MP_0002055'>diabetes</z:mp> was nearly 2.0% per year </plain></SENT>
<SENT sid="9" pm="."><plain>For those who developed <z:mpath ids='MPATH_579'>ulcers</z:mpath>, morbidity, mortality, and excess care costs were substantial compared with those for patients without foot <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>The results appear to support the value of foot-<z:mpath ids='MPATH_579'>ulcer</z:mpath> prevention programs for patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>